Healthcare-Associated Infections Program
Publications
Interim Work Exclusion Guidance for Healthcare
Infection Control Assessment & Response (ICAR) Program
This document is Carbapenem-resistant Enterobacteriaceae and Carbapenem Resistant Pseudomonas aeruginosa lab guidance.
Frequently Asked Questions for Clinicians about Carbapenem-resistant Enterobacteriaceae.
Frequently Asked Questions for Patients about Carbapenem-resistant Enterobacteriaceae.
This is a document about Carbapenem-resistant Enterobacteriaceae Healthcare Facility Level Prevention Strategies.
Healthcare-associated Infections Reporting Group List of Participating Facilities
Hand Sanitizing Basics
Personal Protective Equipment Donning and Removing Sequence
Speak Up: 5 Things You Can Do to Prevent Infections
The goal of this collaborative is to work together to prevent bloodstream infections in hemodialysis and spur a broader interest in preventing infections among the dialysis community.
Frequently Asked Questions about Central Line Associated Bloodstream Infections.
Frequently Asked Questions about Surgical Site Infections.
Frequently Asked Questions about Methicillin-Resistant Staphylococcus Aureus.
Definitions of commonly used terms related to Healthcare-Associated Infections.
Map and list of facilities in New Mexico which voluntarily report Heathcare-Associated Infections.
In response to the increasing concerns about the public health impact of healthcare-associated infections, the United States Department of Health and Human Services has developed an Action Plan to Prevent Healthcare-Associated Infections. The Action Plan includes recommendations for surveillance, research, communication and metrics for measuring progress towards national goals.
Hospital Acquired Infection